Biocon shares jump 5.5% as USFDA clears biosimilar…

[ad_1] Biocon's share price surged 5.5 percent in intra-day trade on Friday, April 11, after the company’s subsidiary, Biocon Biologics, received approval from the US Food and Drug Administration (USFDA) for JOBEVNE, a biosimilar version…